icon-folder.gif   Conference Reports for NATAP  
 
  ID Week
Oct 11-15 2023
Boston, MA

 Back grey_arrow_rt.gif
 
 
 
Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multi-Drug Resistant HIV: Week 104 Results
 
 
  IDWeek, 11-15 October 2023, Boston, Massachusetts, US

1012231

1012232

1012233

1012234

1012235

1012236

1012237

1012238

1012239